T. Rowe Price Associates »

Supernus Pharmaceuticals shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 47k 31.18
2024-06-30 $1.3M 48k 26.77
2024-03-31 $15M 443k 34.11
2023-12-31 $13M 445k 28.94
2023-09-30 $13M 477k 27.57
2023-06-30 $15M 513k 30.06
2023-03-31 $19M 510k 36.23
2022-12-31 $18M 509k 35.67
2022-03-31 $17M 516k 32.32
2021-12-31 $15M 517k 29.16
2021-09-30 $14M 522k 26.67
2021-06-30 $19M 607k 30.79
2021-03-31 $16M 608k 26.18
2020-12-31 $16M 635k 25.16
2020-09-30 $15M 694k 20.84
2020-06-30 $17M 695k 23.75
2020-03-31 $12M 687k 17.99
2019-12-31 $19M 779k 23.72
2019-09-30 $21M 760k 27.48
2019-06-30 $26M 772k 33.09
2019-03-31 $27M 770k 35.04
2018-12-31 $26M 768k 33.22
2018-09-30 $39M 774k 50.35
2018-06-30 $46M 761k 59.85
2018-03-31 $32M 704k 45.80
2017-12-31 $28M 709k 39.85
2017-06-30 $27M 622k 43.10
2017-03-31 $18M 585k 31.30
2016-12-31 $7.9M 314k 25.25
2016-09-30 $561k 23k 24.73
2016-06-30 $995k 49k 20.36
2016-03-31 $671k 44k 15.25
2015-12-31 $6.4M 478k 13.44
2015-09-30 $14M 979k 14.03
2015-03-31 $13M 1.1M 12.09
2014-12-31 $12M 1.4M 8.30
2014-06-30 $38M 3.4M 10.95
2014-03-31 $37M 4.2M 8.94
2013-12-31 $33M 4.4M 7.54
2013-09-30 $33M 4.5M 7.33
2013-06-30 $31M 4.7M 6.43
2013-03-31 $27M 4.8M 5.62
2012-12-31 $34M 4.8M 7.17
2012-09-30 $35M 3.0M 11.55
2012-06-30 $28M 3.0M 9.36